Advances in reversible covalent kinase inhibitors

2024-9-17

Current nanocomposite advances for biomedical and environmental application diversity

2024-9-17

Estrogen deficiency‐mediated osteoimmunity in postmenopausal osteoporosis

2024-9-5

Activation and inhibition of sirtuins: From bench to bedside

2024-8-31

Deciphering the enigmas of non‐nucleoside reverse transcriptase inhibitors (NNRTIs): A medicinal chemistry expedition towards combating HIV drug resistance

2024-8-26

A comprehensive overview on the crosstalk between microRNAs and viral pathogenesis and infection

2024-8-26

Unveiling gut microbiota's role: Bidirectional regulation of drug transport for improved safety

2024-8-24

Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders

2024-8-24

The recent advance and prospect of poly(ADP‐ribose) polymerase inhibitors for the treatment of cancer

2024-8-24

Fenamates: Forgotten treasure for cancer treatment and prevention: Mechanisms of action, structural modification, and bright future

2024-8-22

Canonical effects of cytokines on glomerulonephritis: A new outlook in nephrology

2024-8-20

Targeting tumor microenvironment with photodynamic nanomedicine

2024-8-16

Natural and synthetic 5‐(3′‐indolyl)oxazoles: Biological activity, chemical synthesis and advanced molecules

2024-8-16

Incretin‐based therapies for the management of cardiometabolic disease in the clinic: Past, present, and future

2024-8-14

Pyroptosis and the fight against lung cancer

2024-8-12

OGG1: An emerging multifunctional therapeutic target for the treatment of diseases caused by oxidative DNA damage

2024-8-9

Inside Front Cover Image, Volume 44, Issue 5

2024-8-6

Issue Information

2024-8-6

Front Cover Image, Volume 44, Issue 5

2024-8-6

Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases

2024-7-19

Poly (adenosine diphosphate‐ribose) polymerase inhibitors in the treatment of triple‐negative breast cancer with homologous repair deficiency

2024-6-24

Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future

2024-6-17

Issue Information

2024-6-8

Front Cover Image, Volume 44, Issue 4

2024-6-8

The antisickling agent, 5‐hydroxymethyl‐2‐furfural: Other potential pharmacological applications

2024-6-6

Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands

2024-5-29

Counter‐intuitive discovery in the formulation of poorly water‐soluble drugs: Amorphous small‐molecule gels

2024-5-28

Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer

2024-5-20

Bivalent and bitopic ligands of the opioid receptors: The prospects of a dual approach

2024-5-15

Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel

2024-5-7

Targeting lysosomal quality control as a therapeutic strategy against aging and diseases

2024-5-6

Engineering peptide drug therapeutics through chemical conjugation and implication in clinics

2024-5-5

Innovative pathological network‐based multitarget approaches for Alzheimer's disease treatment

2024-4-28

An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators

2024-4-25

Beyond dopamine: Novel strategies for schizophrenia treatment

2024-4-23

Pharmacological characterization of allosteric modulators: A case for chemokine receptors

2024-4-18

1,2,4,5‐Tetraoxane derivatives/hybrids as potent antimalarial endoperoxides: Chronological advancements, structure−activity relationship (SAR) studies and future perspectives

2024-4-15

Galectin‐8 inhibition and functions in immune response and tumor biology

2024-4-13

A promising future of metal‐<i>N</i>‐heterocyclic carbene complexes in medicinal chemistry: The emerging bioorganometallic antitumor agents

2024-4-9

Issue Information

2024-4-4

The menace of severe adverse events and deaths associated with viral gene therapy and its potential solution

2024-3-28

Benzopyrone, a privileged scaffold in drug discovery: An overview of FDA‐approved drugs and clinical candidates

2024-3-26

Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies

2024-3-26

Elimination of the hepatitis B virus: A goal, a challenge

2024-3-25

Bioactive atropisomers: Unraveling design strategies and synthetic routes for drug discovery

2024-3-21

Most recent advances and applications of extracellular vesicles in tackling neurological challenges

2024-3-18

Enhancing healthy aging with small molecules: A mitochondrial perspective

2024-3-14